Target intelligence / Profile preview

MINDY lysine 48 deubiquitinase 3 (MINDY3)

Target
MINDY3
Molecular classification
Enzyme, Deubiquitinase, Cysteine protease
01

Overview

MINDY lysine 48 deubiquitinase 3 (MINDY3) is an enzyme in humans that belongs to the MINDY (MIU-containing novel DUB family) class of deubiquitinase enzymes, which consists of four members. MINDY3 specifically targets and removes ubiquitin from lysine 48-linked polyubiquitin chains, which signals for proteasomal degradation. By reversing ubiquitination, MINDY3 regulates protein turnover and homeostasis and may play a role in apoptosis and tumor suppression. Like other deubiquitinases (DUBs), MINDY3 functions as a cysteine protease, acting as an exo-DUB (removing ubiquitin units from the distal end of polyubiquitin chains). Deregulation can affect cellular signaling and has implications in cancer, as MINDY3 has been identified as a tumor suppressor. No specific therapeutics are currently approved that directly target MINDY3, but it is recognized as a potential therapeutic target in diseases involving ubiquitin pathway disruption.

Other names
MINDY3Mindy-3Deubiquitinating enzyme MINDY-3
02

Mechanism of action

Deubiquitination of lysine 48-linked polyubiquitin chains (removes ubiquitin from target proteins, regulating their stability and degradation)

03

Biological functions

ApoptosisProtein degradationRegulation of ubiquitin signalingTumor suppression
04

Disease associations

Cancer (acts as a tumor suppressor)Potentially other diseases involving apoptosis or ubiquitin pathway dysregulation

Beyond the preview

Go deeper on MINDY lysine 48 deubiquitinase 3 (MINDY3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MINDY lysine 48 deubiquitinase 3 (MINDY3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call